| Title |
ClinGen — The Clinical Genome Resource
|
|---|---|
| Published in |
New England Journal of Medicine, May 2015
|
| DOI | 10.1056/nejmsr1406261 |
| Pubmed ID | |
| Authors |
Heidi L Rehm, Jonathan S Berg, Lisa D Brooks, Carlos D Bustamante, James P Evans, Melissa J Landrum, David H Ledbetter, Donna R Maglott, Christa Lese Martin, Robert L Nussbaum, Sharon E Plon, Erin M Ramos, Stephen T Sherry, Michael S Watson |
| Abstract |
On autopsy, a patient is found to have hypertrophic cardiomyopathy. The patient's family pursues genetic testing that shows a "likely pathogenic" variant for the condition on the basis of a study in an original research publication. Given the dominant inheritance of the condition and the risk of sudden cardiac death, other family members are tested for the genetic variant to determine their risk. Several family members test negative and are told that they are not at risk for hypertrophic cardiomyopathy and sudden cardiac death, and those who test positive are told that they need to be regularly monitored for cardiomyopathy . . . |
X Demographics
The data shown below were collected from the profiles of 78 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 29 | 37% |
| Saudi Arabia | 6 | 8% |
| United Kingdom | 5 | 6% |
| Colombia | 2 | 3% |
| Brazil | 2 | 3% |
| Spain | 2 | 3% |
| Italy | 2 | 3% |
| Congo | 1 | 1% |
| Venezuela, Bolivarian Republic of | 1 | 1% |
| Other | 2 | 3% |
| Unknown | 26 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 41 | 53% |
| Scientists | 25 | 32% |
| Practitioners (doctors, other healthcare professionals) | 11 | 14% |
| Science communicators (journalists, bloggers, editors) | 1 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 619 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 2% |
| United Kingdom | 6 | <1% |
| Canada | 2 | <1% |
| Spain | 2 | <1% |
| Korea, Republic of | 1 | <1% |
| France | 1 | <1% |
| United Arab Emirates | 1 | <1% |
| Luxembourg | 1 | <1% |
| Unknown | 594 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 123 | 20% |
| Student > Ph. D. Student | 100 | 16% |
| Other | 58 | 9% |
| Student > Master | 54 | 9% |
| Student > Doctoral Student | 38 | 6% |
| Other | 111 | 18% |
| Unknown | 135 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 182 | 29% |
| Medicine and Dentistry | 110 | 18% |
| Agricultural and Biological Sciences | 86 | 14% |
| Computer Science | 22 | 4% |
| Immunology and Microbiology | 9 | 1% |
| Other | 50 | 8% |
| Unknown | 160 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 176. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2024.
All research outputs
#232,926
of 26,017,215 outputs
Outputs from New England Journal of Medicine
#4,239
of 32,765 outputs
Outputs of similar age
#2,358
of 283,863 outputs
Outputs of similar age from New England Journal of Medicine
#46
of 350 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,765 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.4. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,863 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 350 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.